Autolus Therapeutics plc (AUTL)
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Address
THE MEDIAWORKS
LONDON, X0 W12 7FP
Founded
2018
Number of Employees
463
Website
http://www.autolus.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)